Thermo Fisher Scient has 21.11
B in debt with debt to equity (D/E) ratio of 0.66, which is OK given its current industry classification. Thermo Fisher has
performance score of 3 on a scale of 0 to 100. The entity has a beta of 0.1774, which indicates not very significant fluctuations relative to the market. Let's try to break down what Thermo's beta means in this case. As returns on the market increase, Thermo Fisher returns are expected to increase less than the market. However, during the bear market, the loss on holding Thermo Fisher will be expected to be smaller as well. Although it is extremely important to respect
Thermo Fisher Scient current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. By inspecting
Thermo Fisher Scient technical indicators, you can presently evaluate if the expected return of 0.12% will be sustainable into the future.
Thermo Fisher Scient right now has a risk of 2.11%. Please validate Thermo Fisher
information ratio, as well as the
relationship between the potential upside and
kurtosis to decide if Thermo Fisher will be following its existing
price patterns.
We determine the current worth of Thermo Fisher Scientific using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Thermo Fisher Scientific based exclusively on its
fundamental and basic
technical indicators. By analyzing Thermo Fisher's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of
Thermo Fisher's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Thermo Fisher. We calculate exposure to Thermo Fisher's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Thermo Fisher's related companies.
Thermo Fisher Scientific Investment Alerts
Thermo investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Thermo Fisher Scientific performance across your portfolios.Please check all
investment alerts for Thermo
Thermo Fisher Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare Thermo value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Thermo Fisher competition to find
correlations between indicators driving the intrinsic value of Thermo.
Thermo Fisher Gross Profit
Thermo Fisher Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Thermo Fisher previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Thermo Fisher Gross Profit growth over the last 10 years. Please check Thermo Fisher's
gross profit and other
fundamental indicators for more details.
Breaking it down
The entity reported the last year's revenue of 28.5
B. Total Income to common stockholders was 4.88
B with profit before taxes, overhead, and interest of 11.34
B.
Margins Breakdown
Thermo profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Thermo Fisher itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Thermo Fisher profit margins.
| Operating Margin | 14.26 |
| EBITDA Margin | 21.77 |
| Gross Margin | 39.4 |
| Profit Margin | 11.54 |
Thermo Fisher Average Assets is increasing over the last 8 years. The previous year's value of Thermo Fisher Average Assets was 40,204,759,145. Further, Thermo Fisher Earnings Before Interest Taxes and Depreciation Amortization EBITDA is increasing over the last 8 years. The latest value of Thermo Fisher Earnings Before Interest Taxes and Depreciation Amortization EBITDA is 4,856,107,368.
Our Thermo analysis suggests possible reversion in March
The treynor ratio is down to 0.54 as of today. Thermo Fisher Scientific currently demonstrates below-verage downside deviation. It has Information Ratio of -0.03 and Jensen Alpha of 0.07. However, we do advice investors to further question Thermo Fisher Scientific expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.
Our Bottom Line On Thermo Fisher Scient
Whereas some companies within the diagnostics & research industry are still a little expensive, even after the recent corrections, Thermo Fisher may offer a potential longer-term growth to institutional investors. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither buy new shares of Thermo nor trade your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Thermo Fisher.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Thermo Fisher Scientific. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
